U.S. Healthtech Stock News

With the Federal Reserve hinting at a possible pause in rate hikes, a slowing economy, and inflation still above target, interest rate expectations are back in the spotlight. For rate sensitive sectors like real estate and utilities, that combination can reshape borrowing costs, cash flows, and how investors view income producing stocks. This article walks through 3 stocks from our Rate Sensitive Sectors screener that appear more directly exposed to these Fed signals. It highlights how each...

Rising stress in the Federal Reserve’s Main Street Lending Program, where nearly 30% of borrowers are flagged as at risk of default and about 70% struggled with final balloon payments, is putting a harsh spotlight on small business credit risk. For investors, this is less about headline noise and more about which stocks are sitting closest to that pressure. This article breaks down 3 stocks that appear negatively exposed to the latest data on small and midsize business loan performance,...

Navigator Holdings Ltd recently announced that its subsidiaries have secured financing to support the construction and delivery of two new gas carriers in China, with vessel deliveries scheduled for 2027. This fleet expansion underscores the company’s intent to boost liquefied gas transportation capacity, potentially reinforcing its role in a growing niche shipping market. We will now examine how this newly secured vessel financing shapes Navigator Holdings’ investment narrative,...

Artificial intelligence is moving from buzzword to real-world spending priority, even as global inflation, interest rates, and growth trends keep shifting. While central banks weigh inflation risks and bond yields move on policy headlines, companies behind AI chips, software, cloud, and large language models such as ChatGPT sit at the heart of that structural shift. This AI Stocks screener focuses on businesses that are directly tied to that trend, from semiconductors to infrastructure and...

Immunocore Holdings plc recently reported updated Phase 1/2 data for its bispecific T cell receptor therapy brenetafusp in heavily pretreated advanced melanoma at the 2026 American Society of Clinical Oncology Annual Meeting, showing encouraging disease control and six‑month survival in patients with limited treatment options. The consistency of responses even in poor‑prognosis groups, including those with primary PD‑1 resistance, is strengthening confidence in the ongoing Phase 3...

Cost cutting is back in focus after Lucid Group announced plans to trim about 18% of its U.S. workforce, target annualized savings of roughly $158 million, and suspend financial guidance while it reassesses demand and inventory. When a high profile automaker talks openly about efficiency, investors often look for companies that already put discipline and balance sheet health at the center of their story. This article looks at how that theme connects to our Automotive Industry, Cost Efficiency...

AGCO recently announced that its Valtra brand has produced the 1,000th continuously variable transmission at its Suolahti, Finland factory, marking an important milestone in a €38 million investment program to boost local powertrain manufacturing for Valtra, Fendt, and Massey Ferguson tractors. This progress in in‑house CVT production highlights AGCO’s push to tighten control over key components, which could influence manufacturing efficiency, product differentiation, and regional supply...

The housing debate in Washington just got very real for investors. A bipartisan bill to cap institutional ownership of single family homes and encourage new construction puts fresh attention on companies that actually build and deliver housing. If private equity buyers are capped at 350 homes, demand could shift back toward owner occupiers and smaller investors, while incentives for building may support construction activity. Below are 3 stocks from our Homebuilders & Residential Construction...

With Wall Street now bracing for potential rate hikes in 2026 instead of cuts, interest rate sensitivity has jumped back to the top of the checklist for many stock pickers. Persistent 4.2% inflation, a firm labor market, and a hawkish Federal Reserve are reshaping which companies could benefit from higher yields, and which might feel the strain of rising borrowing costs and pressure on real estate and credit. This article breaks down three stocks exposed to that story, spotlighting two that...

Golar LNG (NasdaqGS:GLNG) has attracted fresh attention after recent share price moves, with the stock trading around $49.60. Investors are weighing its liquefied natural gas infrastructure focus in relation to its mixed short term return figures. See our latest analysis for Golar LNG. Recent share price moves around $49.60 come after a year where Golar LNG’s share price return is up 30.70% year to date, while the 3 year total shareholder return of 170.90% and 5 year total shareholder return...

Venture Global (NYSE:VG) has signed new and expanded LNG supply agreements with Germany's EnBW and Greece’s Atlantic-SEE. The Atlantic-SEE contract has been doubled, increasing Venture Global's contracted LNG volumes into Europe. These agreements deepen the company's role as a U.S. LNG supplier to European utilities focused on long-term energy diversification. Venture Global is a U.S. liquefied natural gas exporter, and its latest deals with EnBW and Atlantic-SEE add fresh detail to how the...

It's been a sad week for The Kroger Co. ( NYSE:KR ), who've watched their investment drop 12% to US$56.61 in the week...

Danaher Corporation ( NYSE:DHR ) stock is about to trade ex-dividend in three days. Typically, the ex-dividend date is...

In recent months, Krystal Biotech has seen its institutional shareholding score reach the maximum of 10.00, with major investors such as ETHSX and BlackRock increasing their positions and lifting overall institutional ownership by 11.17% quarter-over-quarter. This sharp rise in institutional participation places Krystal Biotech at the top of its Biotechnology & Medical Research peer group for institutional backing, highlighting stronger professional investor interest despite limited...

Global trade rules are getting tougher, and regulators are paying closer attention to how companies manage compliance, data, and supply chain risk. For investors, that creates a clear filter: focus on businesses that help corporates stay on top of complex rules and avoid costly missteps, and be wary of those that might struggle if governance and audit demands keep building. This article looks at three stocks from a Compliance and Risk Management Software Providers screener that appear well...

With fresh import tariffs returning under the Trump Administration and new trade probes targeting forced labor and industrial overcapacity, investors are being pushed to rethink how exposed their portfolios are to global supply chains. Larger U.S. manufacturers could stand to gain if domestic production becomes relatively more attractive; yet the picture is far from simple. This article breaks down how the renewed tariff push connects to U.S. Domestic Manufacturing Stocks and highlights three...

The SpaceX and Reflection AI deal, worth up to US$6.3b in computing power commitments, puts a fresh spotlight on the infrastructure behind artificial intelligence. This kind of contract shows how valuable high-end chips, data centers, and cloud-style capacity have become for any company trying to scale AI. For investors, it opens up a chance to reassess which stocks might benefit from rising demand for compute and which could be left on the sidelines. This article walks through 3 stocks from...

The United States market has experienced a steady climb, rising 1.4% over the last week and 26% over the past year, with earnings projected to grow by 19% annually in the coming years. In this context, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on discounts relative to their intrinsic value amidst overall market optimism.

The market has shown positive momentum, climbing 1.4% over the last week and 26% over the past year, with earnings anticipated to grow by 19% annually. While penny stocks may seem like a term from a bygone era, they still offer potential for significant returns when aligned with solid financial foundations. In this context, we explore three compelling penny stocks that demonstrate both balance sheet strength and promising growth potential.

The U.S. decision to grant a temporary license for Iranian oil exports adds a fresh twist to the energy story, with extra supply potential and questions around the Strait of Hormuz all feeding into cost expectations for heavy oil users. For companies in transportation, chemicals, and logistics, even small shifts in fuel prices can influence margins, pricing power, and investor sentiment. This article looks at 3 stocks from the Oil-Importing Industries screener that may warrant closer review...

RealReal (REAL) has drawn fresh attention after recent trading, with the stock moving sharply over the past month and over the past three months. Investors are weighing that price action against the company’s resale luxury marketplace profile. See our latest analysis for RealReal. Recent trading has come on top of a strong run in RealReal’s share price, with a 30 day share price return of 35.33% and a 90 day share price return of 40.68%, set against a year to date share price decline of...

Edgewise Therapeutics (EWTX) drew fresh investor attention after reporting favorable Phase 2 Part D CIRRUS-HCM data for EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy, with results supporting progression to Phase 3 development. See our latest analysis for Edgewise Therapeutics. The Phase 2 CIRRUS-HCM update lands at a time when Edgewise Therapeutics has already seen strong momentum, with a 1-month share price return of 12.57% and a year-to-date share price return of...

Geopolitics, central bank shifts, and a surprise box office hit are all feeding into the same question for investors right now: which consumer-focused stocks might be better positioned for the next phase of market sentiment and which might be more exposed to the risks. This article looks at how easing Middle East tensions, fresh signals from the Federal Reserve after Alan Greenspan’s passing, political change in the U.K., and the strong “Toy Story 5” performance could matter for larger...

Markets are watching the Supreme Court and the Federal Reserve almost as closely as earnings reports right now, as questions over central bank independence and possible political pressure on monetary policy add a fresh layer of risk for portfolios. When trust in the Fed is in focus, many investors look again at large U.S. defensive stocks that may offer relatively steadier business profiles if volatility picks up. This article explains how that backdrop could influence your positioning and...